ArticleACS medicinal chemistry letters2022

Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.